Prostate News and Research

RSS

Red wine protects men from prostate cancer

Researchers have found that men who drink an average of four to seven glasses of red wine per week are only 52% as likely to be diagnosed with prostate cancer as those who do not drink red wine, reports the June 2007 issue of Harvard Men's Health Watch .

22 May 2007

New breast cancer treatment may dispense with the need for chemotherapy

According to the latest research new hormone therapy drugs designed to treat breast cancer may dispense with the need for chemotherapy thus avoiding the nasty side effects associated with the treatment.

21 May 2007

Demand for VScan diagnostic test kits increases

Medical Services International Inc (Pink Sheets: MSITF) wishes to announce that as the mosquito season begins in different parts of the world; demand for the VScan diagnostic test kits that detect mosquito borne diseases is increasing. In particular, the demand is for VScan test kits that detect Malaria, Dengue Fever and West Nile.

18 May 2007

Study breaks link between lycopene and prostate cancer prevention

Tomatoes might be nutritious and tasty, but don't count on them to prevent prostate cancer.

18 May 2007

Possible neuroprotective effect of testosterone treatment in men

A small pilot study suggests that testosterone treatment is safe, well tolerated and may reduce symptoms, slow brain degeneration and increase muscle mass in men with relapsing-remitting multiple sclerosis, the most common form of the disease, according to a report in the May issue of Archives of Neurology, one of the JAMA/Archives journals.

17 May 2007

Cancer cells can be killed by a new cancer drug that is triggered by a laser light

Their paper describes how these new photosensitizer drugs can only be activated by light once they have been localized in the target tumour cells. For the first time Zheng and Wilson have demonstrated that tumour cells can be selectively attacked using a PDT.

17 May 2007

Multivitamins linked to prostate cancer

According to a new study men who take a large number of multivitamins might be increasing their risk of developing prostate cancer.

16 May 2007

Mount Sinai uses breakthrough treatment for spinal cancer

The Mount Sinai Medical Center is the only hospital in New York City using the Novalis Shaped Beam Surgery System on spinal cancer.

16 May 2007

Taking too many multivitamins may be linked to advanced prostate cancer

While regular multivitamin use is not linked with early or localized prostate cancer, taking too many multivitamins may be associated with an increased risk for advanced or fatal prostate cancers, according to a study in the May 16 issue of the Journal of the National Cancer Institute.

16 May 2007

Breakthrough in prevention of post-surgical urinary incontinence

Thousands of men facing surgical removal of the prostate due to cancer may someday have one less thing to worry about: post-surgical urinary incontinence.

16 May 2007

Epidemiology of obesity, pathophysiology, associated disease and management

Due to the gastrointestinal tract's role in body weight regulation, gastroenterologists should work closely with other medical disciplines to oversee and coordinate the care of obese individuals, according to an American Gastroenterological Association (AGA) Institute Obesity Task Force Report.

15 May 2007

Estrogen may influence the risk for prostate cancer

Although women are four times more likely than men to develop osteoporosis, or porous bone, one in 12 men also suffer from the disease, which can lead to debilitating - or even life-threatening - fractures, mainly of the spine, hip and wrist.

11 May 2007

Frequent urination often indicates an underlying medical condition

An increase in the number of trips to the bathroom - day or night - is a signal it's time to see a physician.

10 May 2007

Structural variation in the human genome

A major new effort to uncover the medium- and large-scale genetic differences between humans may soon reveal DNA sequences that contribute to a wide range of diseases, according to a paper by Howard Hughes Medical Institute investigator Evan Eichler and 17 colleagues published in the May 10, 2007, Nature.

10 May 2007

Study implicates protein as a trigger of advanced prostate cancer recurrence

Scientists with the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill have for the first time implicated a growth-promoting cellular protein as one trigger of the inevitable recurrence of advanced prostate cancer in men who are undergoing drug treatment to shut down their sex hormones, or androgens.

9 May 2007

Sigma-Aldrich acquires Molecular Medicine BioServices

Sigma-Aldrich Corporation has announced that it has acquired Molecular Medicine BioServices Inc. (MMB), a biopharmaceutical contract manufacturing organization (CMO) located in Carlsbad, California, to further enhance the biologics capabilities within its SAFC Pharma business segment.

9 May 2007

Promising new target for brain tumor therapy

A drug that targets the body's immune cells may be effective in treating malignant brain tumors, according to a new study led by researchers from Duke's Preston Robert Tisch Brain Tumor Center.

9 May 2007

VCU to develop new form of radiation therapy

The National Cancer Institute has awarded a five-year, $10.7 million grant to Virginia Commonwealth University Massey Cancer Center researchers to develop a new form of radiation therapy that will enable the safe administration of more aggressive cancer treatments.

9 May 2007

MRI and MRS can provide a 'road map' of the prostate

MRI and MRS can provide a roadmap of the prostate and assist in surgical planning of robotically assisted laparoscopic radical prostatectomy (RALRP), according to a recent study conducted by researchers at the University of California, Los Angeles.

8 May 2007

MR imaging helps predict recurrence in prostate cancer patients

MR images taken of prostate cancer patients prior to treatment that show that the cancer has spread outside the prostate gland capsule help predict whether the cancer will return, according to a recent study conducted by radiologists at the University of California-San Francisco.

8 May 2007